A detailed history of Weaver Consulting Group transactions in Merck & Co., Inc. stock. As of the latest transaction made, Weaver Consulting Group holds 3,342 shares of MRK stock, worth $387,170. This represents 0.16% of its overall portfolio holdings.

Number of Shares
3,342
Previous 3,342 -0.0%
Holding current value
$387,170
Previous $440,000 6.14%
% of portfolio
0.16%
Previous 0.17%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 13, 2023

SELL
$102.95 - $114.33 $20,590 - $22,866
-200 Reduced 5.65%
3,342 $344,000
Q2 2023

Jul 19, 2023

SELL
$108.61 - $118.38 $12,815 - $13,968
-118 Reduced 3.22%
3,542 $408,000
Q1 2023

Apr 11, 2023

BUY
$102.94 - $114.86 $514 - $574
5 Added 0.14%
3,660 $389,000
Q4 2022

Jan 09, 2023

SELL
$87.44 - $112.11 $4,809 - $6,166
-55 Reduced 1.48%
3,655 $0
Q2 2022

Jul 20, 2022

BUY
$83.49 - $94.64 $10,436 - $11,830
125 Added 3.49%
3,710 $338,000
Q1 2022

May 06, 2022

SELL
$73.51 - $82.4 $1,984 - $2,224
-27 Reduced 0.75%
3,585 $294,000
Q4 2021

Feb 01, 2022

SELL
$72.28 - $90.54 $722 - $905
-10 Reduced 0.28%
3,612 $277,000
Q3 2021

Oct 28, 2021

BUY
$71.68 - $78.83 $645 - $709
9 Added 0.25%
3,622 $272,000
Q2 2021

Jul 06, 2021

SELL
$70.31 - $77.77 $8,859 - $9,799
-126 Reduced 3.37%
3,613 $281,000
Q1 2021

Apr 07, 2021

BUY
$68.86 - $81.11 $51,507 - $60,670
748 Added 25.01%
3,739 $288,000
Q4 2020

Jan 29, 2021

BUY
$71.77 - $79.65 $717 - $796
10 Added 0.34%
2,991 $245,000
Q3 2020

Oct 28, 2020

SELL
$73.18 - $82.95 $5,708 - $6,470
-78 Reduced 2.55%
2,981 $247,000
Q2 2020

Jul 24, 2020

BUY
$70.42 - $80.13 $1,971 - $2,243
28 Added 0.92%
3,059 $237,000
Q4 2019

Jan 31, 2020

BUY
$77.58 - $87.54 $47,323 - $53,399
610 Added 25.2%
3,031 $255,000
Q3 2019

Nov 22, 2019

BUY
$76.08 - $82.93 $7,608 - $8,293
100 Added 4.31%
2,421 $202,000
Q1 2019

Jun 19, 2019

BUY
$69.58 - $79.36 $161,495 - $184,194
2,321 New
2,321 $191,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $293B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Weaver Consulting Group Portfolio

Follow Weaver Consulting Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weaver Consulting Group, based on Form 13F filings with the SEC.

News

Stay updated on Weaver Consulting Group with notifications on news.